|
Company:
|
ELECTROCORE, INC. (ECOR)
|
|
Form Type:
|
8-K
|
|
Filing Date:
|
6/23/2022
|
|
CIK:
|
0001560258
|
|
Address:
|
200 FORGE WAY
SUITE 205
|
|
City, State, Zip:
|
ROCKAWAY, New Jersey 07866
|
|
Telephone:
|
973-290-0097
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$0.53
|
Change:
-0.006 (-1.04%)
|
Trade Time:
Jun 27
|
Market Cap:
$37.72M
|
|
|
|
|
|
|
Description of Business
|
|
We are a commercial stage medical device company with a proprietary non-invasive
vagus nerve stimulation, or nVNS, therapy. nVNS is a platform bioelectronic
medical therapy that modulates neurotransmitters through its effects on both the
peripheral and central nervous systems.
Our gammaCore treatment is the first FDA-cleared, prescription-only nVNS
therapy. Historically, vagus nerve stimulation, or VNS, required an invasive
surgical procedure to permanently implant a costly medical device. This
limitation has generally prevented VNS from being used, other than by the most
severe patients. Our lead product, gammaCore Sapphire, is a proprietary,
simple-to-use handheld delivery system intended for multi-year use. Currently,
it is largely prescribed on a timed basis in 31-day or 93-day increments, or
with a predefined number of stimulations, in a Durable Medical Equipment, or
DME, configuration and may be both rechargeable and reloadable.
|
|
|
|